Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yun-Ju KWON, Chang-Ji ZHENG & Won-Gon KIM. (2010) Isolation and Identification of FR198248, a Hydroxylated 1,3-Dihydroisobenzofuran, from Aspergillus flavipes as an Inhibitor of Peptide Deformylase. Bioscience, Biotechnology, and Biochemistry 74:2, pages 390-393.
Read now
Read now
Anshika Sharma, Gopal K Khuller & Sadhna Sharma. (2009) Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery. Expert Opinion on Therapeutic Targets 13:7, pages 753-765.
Read now
Read now
Garyphallia Poulakou & Helen Giamarellou. (2007) Investigational treatments for postoperative surgical site infections. Expert Opinion on Investigational Drugs 16:2, pages 137-155.
Read now
Read now
Articles from other publishers (34)
Kajal Chakraborty, Vinaya Kizhakkepatt Kizhakkekalam & Minju Joy. (2022) Polyketide-derived macrobrevins from marine macroalga-associated Bacillus amyloliquefaciens as promising antibacterial agents against pathogens causing nosocomial infections. Phytochemistry 193, pages 112983.
Crossref
Crossref
Kajal Chakraborty, Vinaya Kizhakkepatt Kizhakkekalam, Minju Joy & Shubhajit Dhara. (2021) Difficidin class of polyketide antibiotics from marine macroalga-associated Bacillus as promising antibacterial agents. Applied Microbiology and Biotechnology 105:16-17, pages 6395-6408.
Crossref
Crossref
John BremnerJohn Bremner. 2021. Multiple Action-Based Design Approaches to Antibacterials. Multiple Action-Based Design Approaches to Antibacterials
121
158
.
Kajal Chakraborty, Vinaya Kizhakkepatt Kizhakkekalam, Minju Joy & Rekha Devi Chakraborty. (2020) Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives?. Applied Microbiology and Biotechnology 104:16, pages 7117-7130.
Crossref
Crossref
Vinaya Kizhakkepatt Kizhakkekalam, Kajal Chakraborty & Minju Joy. (2020) Oxygenated elansolid-type of polyketide spanned macrolides from a marine heterotrophic Bacillus as prospective antimicrobial agents against multidrug-resistant pathogens. International Journal of Antimicrobial Agents 55:3, pages 105892.
Crossref
Crossref
Raivis Žalubovskis & Jean-Yves Winum. (2019) Inhibitors of Selected Bacterial Metalloenzymes. Current Medicinal Chemistry 26:15, pages 2690-2714.
Crossref
Crossref
Madhu Yadav, Ritika Srivastava, Farha Naaz & Ramendra K. Singh. (2018) Synthesis, docking, ADMET prediction, cytotoxicity and antimicrobial activity of oxathiadiazole derivatives. Computational Biology and Chemistry 77, pages 226-239.
Crossref
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery
435
480
.
Fengping Lv, Chen Chen, Yang Tang, Jianhai Wei, Tong Zhu & Wenhao Hu. (2016) New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment. Bioorganic & Medicinal Chemistry Letters 26:15, pages 3714-3718.
Crossref
Crossref
Xiaofeng Bao, Bryce E. Nickels & Huizhou Fan. (2012)
Chlamydia trachomatis
protein GrgA activates transcription by contacting the nonconserved region of σ
66
. Proceedings of the National Academy of Sciences 109:42, pages 16870-16875.
Crossref
Crossref
Yun-Ju Kwon, Mi-Jin Sohn, Chang-Jin Kim, Hiroyuki Koshino & Won-Gon Kim. (2012)
Flavimycins A and B, Dimeric 1,3-Dihydroisobenzofurans with Peptide Deformylase Inhibitory Activity from
Aspergillus flavipes
. Journal of Natural Products 75:2, pages 271-274.
Crossref
Crossref
P Rolan, H Sun, C MacLeod, K Bracken & T G Evans. (2011) Pharmacokinetics and Unexpected Safety Issues of LBM415, a Novel Oral Peptide Deformylase Inhibitor. Clinical Pharmacology & Therapeutics 90:2, pages 256-262.
Crossref
Crossref
Christopher B Oey. (2011) High tolerance to mutations in a Chlamydia trachomatis peptide deformylase loop. World Journal of Biological Chemistry 2:5, pages 90.
Crossref
Crossref
Patrick J. Gross & Stefan Bräse. (2010) The Total Synthesis of (±)‐Fumimycin. Chemistry – A European Journal 16:42, pages 12660-12667.
Crossref
Crossref
Seung Kyu Lee, Kwang Hyun Choi, Sang Jae Lee, Se Won Suh, B. Moon Kim & Bong Jin Lee. (2010) Peptide deformylase inhibitors with retro-amide scaffold: Synthesis and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters 20:15, pages 4317-4319.
Crossref
Crossref
Anshika Sharma, G.K. Khuller, A.J. Kanwar & Sadhna Sharma. (2010) Therapeutic potential of peptide deformylase inhibitors against experimental tuberculosis. Journal of Infection 60:6, pages 498-501.
Crossref
Crossref
Patrick J. Gross, Caroline E. Hartmann, Martin Nieger & Stefan Bräse. (2009) Synthesis of Methoxyfumimycin with 1,2-Addition to Ketimines. The Journal of Organic Chemistry 75:1, pages 229-232.
Crossref
Crossref
Shannon B Falconer & Eric D Brown. (2009) New screens and targets in antibacterial drug discovery. Current Opinion in Microbiology 12:5, pages 497-504.
Crossref
Crossref
Anshika Sharma, Sadhna Sharma, G.K. Khuller & A.J. Kanwar. (2009) In vitro and ex vivo activity of peptide deformylase inhibitors against Mycobacterium tuberculosis H37Rv. International Journal of Antimicrobial Agents 34:3, pages 226-230.
Crossref
Crossref
Knut Ohlsen, Martin Eckart, Ulrich Dobrindt, Heike Bruhn & Jörg Hacker. 2009. Antiparasitic and Antibacterial Drug Discovery. Antiparasitic and Antibacterial Drug Discovery
373
413
.
Alexander K. Berg & D. K. Srivastava. (2009)
Delineation of Alternative Conformational States in
Escherichia coli
Peptide Deformylase via Thermodynamic Studies for the Binding of Actinonin
. Biochemistry 48:7, pages 1584-1594.
Crossref
Crossref
Caroline E. Hartmann, Patrick J. Gross, Martin Nieger & Stefan Bräse. (2009) Towards an asymmetric synthesis of the bacterial peptide deformylase (PDF) inhibitor fumimycin. Organic & Biomolecular Chemistry 7:24, pages 5059.
Crossref
Crossref
Amit Balakrishnan, Lingling Wang, Xiaojin Li, Pamela Ohman-Strickland, Paul Malatesta & Huizhou Fan. (2009) Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor. Microbiological Research 164:3, pages 338-346.
Crossref
Crossref
Arkadius Pichota, Jeyaraj Duraiswamy, Zheng Yin, Thomas H. Keller, Jenefer Alam, Sarah Liung, Gladys Lee, Mei Ding, Gang Wang, Wai Ling Chan, Mark Schreiber, Ida Ma, David Beer, Xinyi Ngew, Kakoli Mukherjee, Mahesh Nanjundappa, Jeanette W.P. Teo, Pamela Thayalan, Amelia Yap, Thomas Dick, Wuyi Meng, Mei Xu, James Koehn, Shi-Hao Pan, Kirk Clark, Xiaoling Xie, Carolyn Shoen & Michael Cynamon. (2008) Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results. Bioorganic & Medicinal Chemistry Letters 18:24, pages 6568-6572.
Crossref
Crossref
Gang Shen, Jinge Zhu, Anthony M. Simpson & Dehua Pei. (2008) Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors. Bioorganic & Medicinal Chemistry Letters 18:10, pages 3060-3063.
Crossref
Crossref
Knut OhlsenUdo Lorenz. (2007)
Novel targets for antibiotics in
Staphylococcus aureus
. Future Microbiology 2:6, pages 655-666.
Crossref
Crossref
Chang-Ji Zheng, Sangku Lee, Choong-Hwan Lee & Won-Gon Kim. (2007)
Macrolactins O–R, Glycosylated 24-Membered Lactones from
Bacillus
sp. AH159-1
. Journal of Natural Products 70:10, pages 1632-1635.
Crossref
Crossref
Yun-Ju Kwon, Mi-Jin Sohn, Chang-Ji Zheng & Won-Gon Kim. (2007)
Fumimycin: A Peptide Deformylase Inhibitor with an Unusual Skeleton Produced by
Aspergillus
fumisynnematus
. Organic Letters 9:13, pages 2449-2451.
Crossref
Crossref
Michael J Pucci. (2007) Novel Genetic Techniques and Approaches in the Microbial Genomics Era. Drugs in R & D 8:4, pages 201-212.
Crossref
Crossref
Jung-Sung Yoo, Chang-Ji Zheng, Sangku Lee, Jin-Hwan Kwak & Won-Gon Kim. (2006) Macrolactin N, a new peptide deformylase inhibitor produced by Bacillus subtilis. Bioorganic & Medicinal Chemistry Letters 16:18, pages 4889-4892.
Crossref
Crossref
Franz von Nussbaum, Michael Brands, Berthold Hinzen, Stefan Weigand & Dieter Häbich. (2006) Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?. Angewandte Chemie International Edition 45:31, pages 5072-5129.
Crossref
Crossref
Franz von Nussbaum, Michael Brands, Berthold Hinzen, Stefan Weigand & Dieter Häbich. (2006) Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?. Angewandte Chemie 118:31, pages 5194-5254.
Crossref
Crossref
Amit Balakrishnan, Bhairavi Patel, Stephan A. Sieber, Ding Chen, Niseema Pachikara, Guangming Zhong, Benjamin F. Cravatt & Huizhou Fan. (2006) Metalloprotease Inhibitors GM6001 and TAPI-0 Inhibit the Obligate Intracellular Human Pathogen Chlamydia trachomatis by Targeting Peptide Deformylase of the Bacterium. Journal of Biological Chemistry 281:24, pages 16691-16699.
Crossref
Crossref
Zhengyu Yuan & Richard J. White. (2006) The evolution of peptide deformylase as a target: Contribution of biochemistry, genetics and genomics. Biochemical Pharmacology 71:7, pages 1042-1047.
Crossref
Crossref